{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:57:17Z","timestamp":1762505837831},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:00:00Z","timestamp":1321488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00296-011-2220-4","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:44:29Z","timestamp":1321490669000},"page":"3587-3590","source":"Crossref","is-referenced-by-count":26,"title":["Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab"],"prefix":"10.1007","volume":"32","author":[{"given":"Jin-Kyoung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Gyul","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Seon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Soon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Hee","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"2220_CR1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487\u20131498","journal-title":"N Engl J Med"},{"key":"2220_CR2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47:614\u2013622","journal-title":"Arthritis Rheum"},{"key":"2220_CR3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/acr.20212","volume":"62","author":"PA Morganroth","year":"2010","unstructured":"Morganroth PA, Kreider ME, Werth VP (2010) Mycophenolate mofetil for interstitial lung disease in dermatomyositis. Arthritis Care Res (Hoboken) 62:1496\u20131501","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2220_CR4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10067-006-0325-z","volume":"26","author":"S Dold","year":"2007","unstructured":"Dold S, Justiniano ME, Marquez J, Espinoza LR (2007) Treatment of early and refractory dermatomyositis with infliximab: a report of two cases. Clin Rheumatol 26:1186\u20131188","journal-title":"Clin Rheumatol"},{"key":"2220_CR5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/rheumatology\/keh062","volume":"43","author":"H Sprott","year":"2004","unstructured":"Sprott H, Glatzel M, Michel BA (2004) Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1. Rheumatology 43:524\u2013526","journal-title":"Rheumatology"},{"key":"2220_CR6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/rheumatology\/keh268","volume":"43","author":"I Uthman","year":"2004","unstructured":"Uthman I, Sayad JE (2004) Refractory polymyositis responding to infliximab. Rheumatology 43:1198\u20131199","journal-title":"Rheumatology"},{"key":"2220_CR7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/rheumatology\/keh079","volume":"43","author":"I Labioche","year":"2004","unstructured":"Labioche I, Liozon E, Weschler B, Loustaud-Ratti V, Soria P, Vidal E (2004) Refractory polymyositis responding to infliximab: extensied follow-up. Rheumatology 43:531\u2013532","journal-title":"Rheumatology"},{"key":"2220_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/keh539","volume":"44","author":"A Anandacoomarasamy","year":"2005","unstructured":"Anandacoomarasamy A, Howe G, Manolios N (2005) Advanced refractory polymyositis responding to infliximab. Rheumatology 44:562\u2013563","journal-title":"Rheumatology"},{"key":"2220_CR9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine TD (2005) Retuximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 52:601\u2013607","journal-title":"Arthritis Rheum"},{"key":"2220_CR10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1523-1747.2002.01869.x","volume":"119","author":"VP Werth","year":"2002","unstructured":"Werth VP, Callen JP, Ang G, Sullivan KE (2002) Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis. J Invest Dermatol 119:617\u2013620","journal-title":"J Invest Dermatol"},{"key":"2220_CR11","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.1780371206","volume":"37","author":"C Gabay","year":"1994","unstructured":"Gabay C, Gay-Croisier F, Roux-Lombard P, Meyer O, Maineti C, Guerne PA et al (1994) Elevated serum levels of interleukin-1 receptor antagonist in polymyositis\/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum 37:1744\u20131751","journal-title":"Arthritis Rheum"},{"key":"2220_CR12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s100670070027","volume":"19","author":"T Shimizu","year":"2000","unstructured":"Shimizu T, Tomita Y, Son K, Nishinarita S, Sawada S, Horie T (2000) Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis. Clin Rheumatol 19:352\u2013359","journal-title":"Clin Rheumatol"},{"key":"2220_CR13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010051165","volume":"99","author":"S Kuru","year":"2000","unstructured":"Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G (2000) Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol (Berlin) 99:585\u2013588","journal-title":"Acta Neuropathol (Berlin)"},{"key":"2220_CR14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0889-857X(02)00025-X","volume":"28","author":"IE Lundberg","year":"2002","unstructured":"Lundberg IE, Dastmalchi M (2002) Possible pathogenic mechanisms in inflammatory myopathies. Rheum Dis Clin N Am 28:799\u2013822","journal-title":"Rheum Dis Clin N Am"},{"key":"2220_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/187153006779025775","volume":"6","author":"H Kameda","year":"2006","unstructured":"Kameda H, Takeuchi T (2006) Recent advances in the treatment of interstitial lung disease in patients with polymyositis\/dermatomyositis. Endocr Metab Immune Disord Drug Targets 6:409\u2013415","journal-title":"Endocr Metab Immune Disord Drug Targets"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2220-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2220-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2220-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:33Z","timestamp":1559028093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2220-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2220-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}